$166.94
-1.65 (-0.98%)
At Close: Jun 03, 2026
Novanta to Present at the CJS Securities 22nd Annual New Ideas for the New Year Investor Conference on Wednesday, January 12, 2022
10:00pm, Thursday, 16'th Dec 2021 Business Wire
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and Charlie Webster, Executive Vice President, are scheduled to present at the CJS Securities 22nd Annual New Ideas for the New Year Investor Conference, which is being held virtually, on Wednesday, January 12, 2022. About Novanta Novanta is a leading global supplier of
Novanta to Present at the CJS Securities 22nd Annual New Ideas for the New Year Investor Conference on Wednesday, January 12, 2022
05:00pm, Thursday, 16'th Dec 2021
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckl
Novanta to Present at the J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022
03:05am, Wednesday, 15'th Dec 2021 Business Wire
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chairperson and Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the J.P. Morgan Healthcare Conference, which is being held in person, on Tuesday, January 11, 2022, in San Francisco, California. About Novanta Novanta is a leading global supplier
Novanta to Present at the J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022
10:05pm, Tuesday, 14'th Dec 2021
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glas
Laser Technology Market to Rise Tremendously; Growing Popularity of Cosmetic Laser Treatment to Bolster Growth, states Fortune Business Insights™
01:31pm, Tuesday, 14'th Dec 2021 Intrado Digital Media
Companies Profiled in the Market: Coherent, Inc., Access Laser Company, Lumenis Ltd., IPG Photonics Corporation, The TRUMPF Group, Lumentum Holdings Inc., Corning Incorporated, Jenoptik AG, Novanta Inc., Lumibird, Laser Star Technologies Corporation. Companies Profiled in the Market: Coherent, Inc., Access Laser Company, Lumenis Ltd., IPG Photonics Corporation, The TRUMPF Group, Lumentum Holdings Inc., Corning Incorporated, Jenoptik AG, Novanta Inc., Lumibird, Laser Star Technologies Corporation.
Reviewing Byrna Technologies (OTCMKTS:BYRN) & Novanta (NASDAQ:NOVT)
07:40am, Tuesday, 14'th Dec 2021 Dakota Financial News
Byrna Technologies (OTCMKTS:BYRN) and Novanta (NASDAQ:NOVT) are both business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, dividends, profitability, risk and institutional ownership. Volatility and Risk Byrna Technologies has a beta of 0.83, indicating that its share price is […]
Comparing Decarbonization Plus Acquisition Co. III (NASDAQ:DCRC) and Novanta (NASDAQ:NOVT)
09:26am, Saturday, 04'th Dec 2021 Dakota Financial News
Novanta (NASDAQ:NOVT) and Decarbonization Plus Acquisition Co. III (NASDAQ:DCRC) are both computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, risk, dividends, institutional ownership and profitability. Analyst Ratings This is a breakdown of recent ratings for Novanta and []
Novanta (NASDAQ:NOVT) Releases Q4 2021 Earnings Guidance
08:12pm, Thursday, 02'nd Dec 2021 Transcript Daily
Novanta (NASDAQ:NOVT) issued an update on its fourth quarter 2021 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $0.600-$0.670 for the period, compared to the Thomson Reuters consensus estimate of $0.650. The company issued revenue guidance of $185 million-$195 million, compared to the consensus revenue estimate of $187.61 million.Novanta []
Novanta (NASDAQ:NOVT) Issues FY 2021 Earnings Guidance
05:58pm, Friday, 26'th Nov 2021 Transcript Daily
Novanta (NASDAQ:NOVT) issued an update on its FY 2021 earnings guidance on Tuesday morning. The company provided EPS guidance of $2.550-$2.620 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.450. The company issued revenue guidance of $693 million-$703 million, compared to the consensus revenue estimate of $689.89 million.Novanta also updated its []
Novanta, Inc. (NOVT) CEO Matthijs Glastra on Q3 2021 Results - Earnings Call Transcript
02:33pm, Tuesday, 09'th Nov 2021
Novanta, Inc. (NOVT) CEO Matthijs Glastra on Q3 2021 Results - Earnings Call Transcript
Novanta (NOVT) Surpasses Q3 Earnings and Revenue Estimates
09:56am, Tuesday, 09'th Nov 2021
Novanta (NOVT) delivered earnings and revenue surprises of 22.95% and 2.61%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Novanta to Present at Baird's 2021 Global Industrial Conference on Wednesday, November 10, 2021
08:36pm, Thursday, 21'st Oct 2021
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glas
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 09, 2021
06:18pm, Monday, 11'th Oct 2021
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarte
Novanta (NOVT) Moves 4.2% Higher: Will This Strength Last?
12:14pm, Thursday, 23'rd Sep 2021
Novanta (NOVT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength do
All You Need to Know About Novanta (NOVT) Rating Upgrade to Strong Buy
01:45pm, Friday, 03'rd Sep 2021
Novanta (NOVT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Sign In
Buy NOVT